Europe — EMA

Emtricitabine/Tenofovir Disoproxil Accordpharma

Emtricitabine/Tenofovir Disoproxil Accordpharma is a combination medication used for HIV treatment and prevention. This oral medication is manufactured by Accor

Emtricitabine, Tenofovir Disoproxil

Request sourcing

Pack/s

What is Emtricitabine, Tenofovir Disoproxil?

Emtricitabine/Tenofovir Disoproxil Accordpharma is a combination medication used for HIV treatment and prevention. This oral medication is manufactured by Accord Healthcare B.V. and is available in the EU.

What is Emtricitabine, Tenofovir Disoproxil used for?

Emtricitabine/Tenofovir Disoproxil Accordpharma is primarily used in the management of HIV infection. It is often prescribed as part of a combination therapy to help control the virus and reduce the risk of transmission. This medication is also used for pre-exposure prophylaxis (PrEP) in individuals at high risk of HIV infection.

What are the side effects of Emtricitabine, Tenofovir Disoproxil?

Common effects of Emtricitabine/Tenofovir Disoproxil Accordpharma may include headaches, nausea, and fatigue. Some users may experience dizziness or changes in mood. It is important to consult a healthcare provider if these effects persist or worsen.

What precautions apply to Emtricitabine, Tenofovir Disoproxil?

Emtricitabine/Tenofovir Disoproxil Accordpharma should be handled with care. It is essential to follow the prescribed dosage and administration instructions. Regular monitoring of kidney function is recommended during treatment. This medication should not be used without medical supervision.

What does Emtricitabine, Tenofovir Disoproxil interact with?

Emtricitabine/Tenofovir Disoproxil Accordpharma may interact with other medications, including certain antibiotics and anticonvulsants. Alcohol consumption should be avoided as it may exacerbate side effects. Always inform your healthcare provider about all medications you are taking.

Frequently asked questions

What is Emtricitabine/Tenofovir Disoproxil Accordpharma used for?+

Emtricitabine/Tenofovir Disoproxil Accordpharma is used for the treatment and prevention of HIV infection. It is often part of a combination therapy to control the virus and reduce transmission risk.

How should Emtricitabine/Tenofovir Disoproxil Accordpharma be taken?+

Emtricitabine/Tenofovir Disoproxil Accordpharma is taken orally, typically once daily. It should be taken with or without food, as directed by a healthcare provider.

What are the common side effects of Emtricitabine/Tenofovir Disoproxil Accordpharma?+

Common side effects may include headaches, nausea, fatigue, dizziness, and changes in mood. If these effects persist or worsen, consult a healthcare provider.

Can Emtricitabine/Tenofovir Disoproxil Accordpharma be used for pre-exposure prophylaxis (PrEP)?+

Yes, Emtricitabine/Tenofovir Disoproxil Accordpharma is approved for use as PrEP in individuals at high risk of HIV infection.

What precautions should be taken when using Emtricitabine/Tenofovir Disoproxil Accordpharma?+

Regular monitoring of kidney function is recommended. Follow the prescribed dosage and avoid alcohol. Consult a healthcare provider before starting any new medications.

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →